Skip to main content
Signal8

Mehta Kishan

SEC insider (Form 3/4/5 filer). CIK 0001850520. Director at Biohaven Ltd. (BHVN) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 28, 2026. Located in NEW HAVEN, CT.

Companies Mehta Kishan has filed insider reports for

  • Biohaven Ltd. (BHVN): Director
  • Benitec Biopharma Inc. (BNTC): Director
Mehta Kishan profile photo

Mehta Kishan

CIK: 0001850520

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Biohaven Ltd. logo
BHVN

Biohaven Ltd.

Director
Benitec Biopharma Inc. logo
BNTC

Benitec Biopharma Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Apr 28, 2026
    Award

    Stock Options (Right to buy)

    Direct
    68.7K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Mar 17, 2026
    Gift
    Direct
    17.3K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    Mar 17, 2026
    Gift
    Indirect
    17.3K shares-
  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Dec 1, 2025
    Award

    Options (right to buy)

    Direct
    35K shares-
  • Biohaven Ltd. logo
    BHVN

    Biohaven Ltd.

    May 5, 2025
    Award

    Stock Options (Right to buy)

    Direct
    31.7K shares-
  • Benitec Biopharma Inc. logo
    BNTC

    Benitec Biopharma Inc.

    Dec 9, 2024
    Award

    Options (right to buy)

    Direct
    35K shares-

1-6 of 6